Profile of ranibizumab: efficacy and safety for the treatment of wet age-related macular degeneration

Overview of attention for article published in Therapeutics and Clinical Risk Management, July 2012

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 41 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?

Article in Drug Design Development and Therapy (February 2024)

Development of the Port Delivery System with ranibizumab for neovascular age-related macular degeneration

Article in Current Opinion in Ophthalmology (March 2022)

Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

Article in Pharmaceutics (September 2021)